Jordan, in the late hours of Monday, announced the approval of emergency use of the Pfizer-BioNTech coronavirus vaccine, the same day the United States started the mass vaccination drive.
However, the Jordanian Food and Drug Administration (JFDA) was not clear when it would begin rolling out the vaccines. Last month, health minister Nazir Obeidat announced that the Pfizer-BioNTech coronavirus vaccine will be distributed for free among foreign residents, as well as Jordanians.
JFDA director-general Nizar Mheidat said that a study was underway to allow the use of two other vaccines, most likely by British pharmaceuticals group AstraZeneca and US group Johnson & Johnson.
The country registered 262,477 cases of COVID-19 amidst its 10 million population, with 3,407 fatal cases. Last week, Jordan opened the first of three military field hospitals to prevent the sharp rise in cases.